±¬ÁϹ«Éçapp

Skip Navigation
  • Why ±¬ÁϹ«Éçapp
  • How It Works
  • Who Uses It
  • Pricing
Return to ±¬ÁϹ«Éçapp homepage
  • News
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • ·¡²Ô±¹¾±°ù´Ç²Ô­³¾±ð²Ô³Ù

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All ·¡²Ô±¹¾±°ù´Ç²Ô­³¾±ð²Ô³Ù

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • °Õ±ð±ô±ð³¦´Ç³¾³¾Â­³Ü²Ô¾±³¦²¹³Ù¾±´Ç²Ô²õ

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All °Õ±ð±ô±ð³¦´Ç³¾³¾Â­³Ü²Ô¾±³¦²¹³Ù¾±´Ç²Ô²õ

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision ±¬ÁϹ«Éçapp provides efficient communication tools to continuously engage with target audiences across multiple online channels
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • ·¡²Ô±¹¾±°ù´Ç²Ô­³¾±ð²Ô³Ù
    • Heavy Industry & Manufacturing
    • °Õ±ð±ô±ð³¦´Ç³¾³¾Â­³Ü²Ô¾±³¦²¹³Ù¾±´Ç²Ô²õ
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • RSS
  • RSS
  • RSS

Compound Solutions' ±·´¡¶Ù3® Ingredient Now Patented with Human Data Showing Benefits Beyond NAD


News provided by

Compound Solutions, Inc.

Jun 16, 2026, 08:35 ET

Share this article

Share toX

Share this article

Share toX

Compound Solutions' ±·´¡¶Ù3® is now patented and backed by first-of-its-kind human efficacy data showing benefits beyond NAD, including improved mitochondrial and cardiovascular function.

CARLSBAD, Calif., June 16, 2026 /PRNewswire-±¬ÁϹ«Éçapp/ -- Compound Solutions, Inc. (CSI), a leading ingredient house supplying science-backed nutraceutical ingredients, today announced that its ingredient is now patented, marking a major validation point in the healthy aging category.

The longevity space has become crowded with NAD supplements built around boosting NAD. But ±·´¡¶Ù3® goes much further than boosting NAD levels in blood, and the patent and human efficacy data support it.

NAD status matters, but an increase in NAD status alone does not automatically mean the body is functioning better. Healthy aging needs a physiological outcome. That is where Compound Solutions' ±·´¡¶Ù3® separates itself from other NAD ingredients.

±·´¡¶Ù3® is one of the first and only NAD supplements with human efficacy data showing physiological benefits beyond improving NAD status. ±·´¡¶Ù3® has been shown to promote mitochondrial and cardiovascular function. It also supports a healthier NAD+/NADH ratio, which matters because mitochondrial function–roughly described as the body's ability to turn food into energy–depends on more than simply having higher NAD levels.

Mitochondrial function sits at the center of healthy aging. When the body's energy systems become less efficient, the impact can show up across metabolic health and long-term function. Poor mitochondrial function is often discussed as an upstream precursor to poor health conditions because when energy systems begin to malfunction, other systems tend to follow.

"For brands formulating for longevity, ±·´¡¶Ù3® offers a patented and clinically supported way to stand apart in a fast-growing category where 'NAD boosting' has quickly become the baseline, ±·´¡¶Ù3® is 'longevity you can feel'. Consumers are becoming more educated, and the next wave of healthy aging products will do more than cellular support; they will need to show why that support matters. We are grateful for our longtime ±·´¡¶Ù3® brand collaborators pushing the category to new highs.", said Matt Titlow, CEO of Compound Solutions.

About Compound Solutions

Compound Solutions (CSI) is one of the most innovative, trusted and credible ingredient houses in the dietary supplement industry. Since 1998, CSI has been the go-to company for science-backed ingredients that lead the way in wellness, gut health, sports nutrition and beyond. CSI's long-lasting relationships with global customers and suppliers have earned it a reputation for collaboration and community. For more information, visit , and follow Compound Solutions on and .

Media Contact

Ryan Harris, Compound Solutions, Inc., 1 7607399886, [email protected],

SOURCE Compound Solutions, Inc.

Modal title

Compound Solutions' ±·´¡¶Ù3® Ingredient is Now Patented
Compound Solutions' ±·´¡¶Ù3® Ingredient is Now Patented
Compound Solutions' ±·´¡¶Ù3® Ingredient is Now Patented

Contact ±¬ÁϹ«Éçapp

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About ±¬ÁϹ«Éçapp

  • About ±¬ÁϹ«Éçapp
  • Partners
  • Partnership Programs
  • Editorial Guidelines

Why ±¬ÁϹ«Éçapp

  • Why ±¬ÁϹ«Éçapp
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

My Services
  • All News Releases
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025±¬ÁϹ«Éçapp.